Zhijie Wang, MD, PhD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Marc Fellous, MD
Sr. Vice President, Clinical Development and Medical Affairs
Shared therapeutic areas:
Ningbo Liu, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Dong Wang, PH.D
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Shared therapeutic areas:
Shun Lu, Professor
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, P. R. China
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Gen Lin, MD,PhD
CSWOG
Shared therapeutic areas:
Gabriella Pravettoni
Istituto Europeo di Oncologia
Shared therapeutic areas:
Glenn Lesser, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Liu Yang, M.D.
Zhejiang Provincial People's Hospital
Shared therapeutic areas:
Shuhang wang, PhD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
All 1 trials loaded